Bastone Bronwen

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 73% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Bastone Bronwen's trades of Enfusion Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-07 2025-03-05
US Enfusion Inc (ENFN)
S Sale
26,033 -1.5%
219.26
US$421,217 		26,033 -1.5% 219.26 US$421,217
2025-03-05 2025-03-05
US Enfusion Inc (ENFN)
PrS Proposed sale
63,198
106.89
US$4,285,189 		63,198 106.89 US$4,285,189
2025-03-05 2025-03-03
US Enfusion Inc (ENFN)
S Sale
99,915 -35.5%
204.71
US$3,761,879 		99,915 -35.5% 204.71 US$3,761,879
2025-03-03 2025-03-03
US Enfusion Inc (ENFN)
PrS Proposed sale
2,064
11.48
US$23,697 		2,064 11.48 US$23,697
2025-01-10 2025-01-07
US Enfusion Inc (ENFN)
S Sale
809 -0.4%
10.13
US$8,195 		809 -0.4% 10.13 US$8,195
2025-01-07 2025-01-07
US Enfusion Inc (ENFN)
PrS Proposed sale
809
10.13
US$8,196 		809 10.13 US$8,196
2024-09-12 2024-09-10
US Enfusion Inc (ENFN)
S Sale
3,219 -1.6%
8.12
US$26,138 		3,219 -1.6% 8.12 US$26,138
2024-09-10 2024-09-10
US Enfusion Inc (ENFN)
PrS Proposed sale
3,219
8.12
US$26,153 		3,219 8.12 US$26,153
2024-06-21 2024-06-20
US Enfusion Inc (ENFN)
S Sale
18,241 -8.4%
8.11
US$147,935 		18,241 -8.4% 8.11 US$147,935
2024-06-20 2024-06-20
US Enfusion Inc (ENFN)
PrS Proposed sale
18,241
8.11
US$147,901 		18,241 8.11 US$147,901
2024-06-21 2024-06-18
US Enfusion Inc (ENFN)
S Sale
10,539 -4.6%
8.17
US$86,104 		10,539 -4.6% 8.17 US$86,104
2024-06-18 2024-06-18
US Enfusion Inc (ENFN)
PrS Proposed sale
10,539
8.17
US$86,128 		10,539 8.17 US$86,128
2024-05-22 2024-05-20
US Enfusion Inc (ENFN)
S Sale
34,059 -13.0%
9.55
US$325,263 		34,059 -13.0% 9.55 US$325,263
2024-05-22 2024-05-20
US Enfusion Inc (ENFN)
S Sale
34,059 -13.0%
9.55
US$325,263 		34,059 -13.0% 9.55 US$325,263
2024-05-20 2024-05-20
US Enfusion Inc (ENFN)
PrS Proposed sale
34,059
9.55
US$325,396 		34,059 9.55 US$325,396
2024-01-10 2024-01-09
US Enfusion Inc (ENFN)
S Sale
410 -0.3%
8.95
US$3,670 		410 -0.3% 8.95 US$3,670
2024-01-09 2024-01-09
US Enfusion Inc (ENFN)
PrS Proposed sale
410
8.95
US$3,670 		410 8.95 US$3,670
2024-01-10 2024-01-08
US Enfusion Inc (ENFN)
S Sale
391 -0.3%
9.23
US$3,609 		391 -0.3% 9.23 US$3,609
2024-01-08 2024-01-08
US Enfusion Inc (ENFN)
PrS Proposed sale
391
9.23
US$3,610 		391 9.23 US$3,610
2023-08-15 2023-08-14
US Enfusion Inc (ENFN)
S Sale
41 -0.0%
7.89
US$323 		41 -0.0% 7.89 US$323
2023-08-14 2023-08-14
US Enfusion Inc (ENFN)
PrS Proposed sale
41
7.89
US$324 		41 7.89 US$324
2023-08-14 2023-08-11
US Enfusion Inc (ENFN)
S Sale
44 -0.0%
8.10
US$356 		44 -0.0% 8.10 US$356
2023-08-11 2023-08-11
US Enfusion Inc (ENFN)
PrS Proposed sale
44
8.10
US$356 		44 8.10 US$356
2023-08-11 2023-08-10
US Enfusion Inc (ENFN)
S Sale
50 -0.0%
8.08
US$404 		50 -0.0% 8.08 US$404
2023-08-10 2023-08-10
US Enfusion Inc (ENFN)
PrS Proposed sale
50
8.08
US$404 		50 8.08 US$404
2023-08-10 2023-08-09
US Enfusion Inc (ENFN)
S Sale
55 -0.0%
8.32
US$458 		55 -0.0% 8.32 US$458
2023-08-09 2023-08-09
US Enfusion Inc (ENFN)
PrS Proposed sale
55
8.32
US$457 		55 8.32 US$457